Worldwide $5.8 Billion Hearing Implants and Biomaterials Market Shares, Strategies, and Forecasts, 2017 to 2023

Dublin, Aug. 23, 2017 (GLOBE NEWSWIRE) -- The "Hearing Implants and Biomaterials: Market Shares, Strategies, and Forecasts, Worldwide 2017 to 2023" report from Wintergreen Research, Inc has been added to Research and Markets' offering.

Hearing Implants and Biomaterial markets are poised to achieve significant growth with increasing use of next generation metals, polymers, and ceramics set to enhance the value of hearing surgery and improve surgical outcomes. By improving hearing of people with profound hearing deficits. Improvements is hearing for severely deaf infants, children and adults particularly old people are dramatic.

Small implant, great results is the norm. The best results were found among children who received the cochlear implant at 0-3 years of age. They achieved 90 to 95 percent hearing and language improvement. 80-90 percent of these children develop a hearing and speech equal to those of children with normal hearing.

Biomaterials inside CI are biological materials that are implanted into the ear area to repair hearing. All CI manufacturers use platinum contacts in electrode production. Iridium oxide coatings have been investigated, which show beneficial effects of impedance.

Biomaterials for hearing implants depend on components, structural polymers, and electrodes. Biomaterials have transformed medical treatment of hearing loss. The ear functioning, hearing loss is able to be addressed with functioning repaired via a device implant that leverages biomaterials.

The cochlear implant has become widely recognized as an established treatment for profound hearing loss. This bodes well for market growth, as there is minimal, less than one percent market penetration now. New materials and greater surgeon experience are expected to reduce the cost of the implant, both the device and the procedure.

Economies of scale always decrease costs and increase market size. The trend likely to continue is for Cochlear implants as medical devices to continue to be used more often. Implants bypass damaged structures in the inner ear and directly stimulate the auditory nerve. They are surgically implanted to improve hearing in people with severe or profound hearing losses. They can create a range of sound, but do not replace normal hearing.

Cochlear implants are not indicated for all hard of hearing or deaf people. They are not recommended in people who function well with hearing aids.

The implant works by picking up incoming sounds. Incoming sounds are converted to electrical currents and directed to a number of contact points on the internal wire. This operation creates an electrical field which directly stimulates the auditory nerve, thus bypassing the defective inner ear. Cochlear implants convert sound waves to electrical impulses and transmit them to the inner ear, providing people with the ability to hear sounds and potentially better understand speech without reading lips.

According to the lead author of the team that prepared the study: Cochlear implants extend the medical device markets by enabling a bypass of damaged structures in the inner ear. They directly stimulate the auditory nerve. They are surgically implanted to improve hearing in people with severe or profound hearing losses. They can create a range of sound, but do not replace normal hearing.

The worldwide market for Hearing Implants and associated biomaterials is $1.8 billion in 2017, anticipated to reach $5.8 billion by 2023. The complete report provides a comprehensive analysis of hearing implants in different categories, illustrating the diversity of uses for devices in auditory surgery by age group. A complete procedure analysis is done, looking at numbers of procedures and doing penetration analysis.

Key Topics:

- Alpha Titanium Alloys
- Alpha-Beta Titanium Alloys
- Annealing - Beta Titanium Alloys
- Biomaterials for Hearing Implants
- Bypass damaged structures
- Convert sound waves
- Electrical field
- Improve hearing in people
- Inner ear
- Near Alpha Titanium Alloys
- Profound hearing loss
- Profound hearing losses
- Sounds are converted to electrical currents
- Stimulate the auditory nerve
- Stimulates the auditory nerve

Key Topics Covered:

1. Biomaterials for Hearing Implants: Market Description and Market Dynamics
1.1 Use Of Cochlear Implants
1.2 Ear Description
1.2.1 Cochlear Implant (CI) System
1.2.2 Biomaterial As A Substance
1.3 Bilateral CI Fitting
1.4 Cochlear Implants Biomaterials
1.4.1 Silicone
1.4.2 Platinum
1.4.3 Titanium
1.4.4 Ceramics
1.5 Biomaterials in Hearing Implant

2. Hearing Implants and Biomaterials Market Shares and Forecasts
2.1 Hearing Implants and Biomaterials Market Driving Forces
2.1.1 Surgical Cochlear Implantation Is By And Large Safe
2.2 Hearing Implant Market Shares
2.2.1 Cochlear
2.2.2 Advanced Bionics AG
2.2.3 Med-EL EAS
2.3 Biomaterials Market Forecasts
2.3.1 Biomaterial Hearing Implant Segments, Children, Adults Age 19 to 50, Adults 51 to 64, Adults Over 65, Market Forecasts
2.3.2 Biomaterial Hearing Implant Market Installed Base Forecasts
2.4 Global Biomaterials Market
2.4.1 Optimizing the Biocompatibility Properties Of The Hearing Implant
2.4.2 Biofilms
2.4.3 Teflon for Cochlear Implants
2.4.4 Electrically Conducting Polymers
2.4.5 Polyimides
2.4.6 Silicon Electrodes
2.4.7 Physical Functionalization Of Surfaces
2.4.8 Drug Delivery In The Inner Ear (Neurotrophic Effects)
2.4.9 BioMaterial Nanoparticles
2.4.10, Nanoparticles And Cochlear Implants
2.4.11, Biomaterials Market Overview
2.5 Cochlear (CI) Implant Technical Specifications
2.5.1 Advanced Bionics Technical Specifications
2.5.2 Cochlear Technical Specifications
2.6 Biomaterials Pricing
2.7 Biomaterials Regional Segment Analysis
2.7.1 United States
2.7.2 Europe
2.7.3 Rapid Development of Middle Class in South America

3. Biomaterial Hearing Implants Product Description
3.1 Cochlear
3.1.1 Cochlear KansoSound Processor
3.1.2 Cochlear Nucleus®6 Sound Processor
3.1.3 Cochlear Hearing Implant Specifications
3.1.4 Cochlear Implant Technical Specifications
3.2 Med-El GmbH's Flex EAS
3.2.1 Med-EL EAS Hearing Implant System for Partial Mild To Moderate Deafness
3.2.2 Hearing Implant Advantages Of Bilateral Implantation
3.2.3 MedEL Implant Concerto
3.2.4 MedEL Implant Concerto Structure Preservation
3.2.1 MedEL Implant Concerto Complete Cochlear Coverage CCC
3.2.2 Med-EL Electrode Arrays
3.2.3 Med-EL FLEX Tip Technology
3.2.4 Med-EL Classic Series
3.2.5 Med-EL FLEX Series
3.2.6 FDA Approves the MED-EL Synchrony EAS Hearing Implant System
3.2.7 Med-EL Addresses Hearing Loss in the US
3.2.8 MED-EL Technical Specifications
3.3 Sonova / Advanced Bionics AG
3.3.1 Advanced Bionics Implant Specifications

4. Biomaterials Research and Technology
4.1 Medical Device Standards and Implant Standards - ASTM International
4.2 Metalic Implants
4.2.1 Unalloyed Titanium
4.2.2 Titanium Alloy
4.3 Hearing Implant Prosthesis Biomaterials

5. Ear Implant Biomaterials Company Profiles
5.1 Cochlear
5.1.1 Cochlear Revenue
5.2 Med-EL Maestro
5.2.1 Med-EL Hearing Implant Concerto
5.2.2 Med-EL Revenue
5.2.3 Med-EL Implantable Solutions
5.3 Nurotron Biotechnology Co., Ltd. (China)
5.3.1 Nurotron Biomaterials Positioning
5.3.2 Nurotron Biotechnology Thin, Ergonomic, Titanium Implant Package
5.3.3 Nurotron Biotechnology Expands Facilities, Staff Ten-Fold
5.3.4 Nurotron Biotechnology Co., Ltd.
5.4 Sonova / Advanced Bionics AG
5.4.1 Sonova Group Revenue / Advanced Bionics
5.4.2 Sonova / Advanced Bionics
5.5 William Demant / Oticon Medical / Neurelec

6. Research Methodology

For more information about this report visit https://www.researchandmarkets.com/research/49x3qp/hearing_implants

                    
                    
                    CONTACT: Research and Markets
                             Laura Wood, Senior Manager
                             press@researchandmarkets.com
                             For E.S.T Office Hours Call 1-917-300-0470
                             For U.S./CAN Toll Free Call 1-800-526-8630
                             For GMT Office Hours Call +353-1-416-8900
                             U.S. Fax: 646-607-1907
                             Fax (outside U.S.): +353-1-481-1716
                             Related Topics: Biomaterials , Hearing Aids and Implants